These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16571793)

  • 1. Vpu and Tsg101 regulate intracellular targeting of the human immunodeficiency virus type 1 core protein precursor Pr55gag.
    Harila K; Prior I; Sjöberg M; Salminen A; Hinkula J; Suomalainen M
    J Virol; 2006 Apr; 80(8):3765-72. PubMed ID: 16571793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Vpu-regulated endocytosis of HIV-1 Gag is clathrin-independent.
    Harila K; Salminen A; Prior I; Hinkula J; Suomalainen M
    Virology; 2007 Dec; 369(2):299-308. PubMed ID: 17822732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane.
    Neil SJ; Eastman SW; Jouvenet N; Bieniasz PD
    PLoS Pathog; 2006 May; 2(5):e39. PubMed ID: 16699598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress.
    Martin-Serrano J; Zang T; Bieniasz PD
    Nat Med; 2001 Dec; 7(12):1313-9. PubMed ID: 11726971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of human immunodeficiency virus type 1 envelope glycoprotein YXXL endocytosis/polarization signal on viral accessory protein functions.
    Cervantes-Acosta G; Lodge R; Lemay G; Cohen EA
    J Hum Virol; 2001; 4(5):249-59. PubMed ID: 11907382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.
    Park J; Morrow CD
    Virology; 1993 Jun; 194(2):843-50. PubMed ID: 8503189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tethered virions are intermediates in the assembly and release of HIV-1 particles.
    Karetnikov A; Suomalainen M
    Virology; 2010 Nov; 407(2):289-95. PubMed ID: 20850859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The N-terminal matrix domain of HIV-1 Gag is sufficient but not necessary for viral protein U-mediated enhancement of particle release through a membrane-targeting mechanism.
    Deora A; Spearman P; Ratner L
    Virology; 2000 Apr; 269(2):305-12. PubMed ID: 10753709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Vpu inhibits accumulation of the envelope glycoprotein within clathrin-coated, Gag-containing endosomes.
    Van Damme N; Guatelli J
    Cell Microbiol; 2008 May; 10(5):1040-57. PubMed ID: 18076669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.
    Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB
    Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel fluorescence resonance energy transfer assay demonstrates that the human immunodeficiency virus type 1 Pr55Gag I domain mediates Gag-Gag interactions.
    Derdowski A; Ding L; Spearman P
    J Virol; 2004 Feb; 78(3):1230-42. PubMed ID: 14722278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 particle release mediated by Vpu is distinct from that mediated by p6.
    Schwartz MD; Geraghty RJ; Panganiban AT
    Virology; 1996 Oct; 224(1):302-9. PubMed ID: 8862425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body.
    Ono A; Freed EO
    J Virol; 2004 Feb; 78(3):1552-63. PubMed ID: 14722309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HIV-1 matrix domain of Gag is required for Vpu responsiveness during particle release.
    Lee YH; Schwartz MD; Panganiban AT
    Virology; 1997 Oct; 237(1):46-55. PubMed ID: 9344906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Vpr Abrogates the Effect of TSG101 Overexpression to Support Virus Release.
    Chutiwitoonchai N; Siarot L; Takeda E; Shioda T; Ueda M; Aida Y
    PLoS One; 2016; 11(9):e0163100. PubMed ID: 27648839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The host protein Staufen1 participates in human immunodeficiency virus type 1 assembly in live cells by influencing pr55Gag multimerization.
    Chatel-Chaix L; Abrahamyan L; Fréchina C; Mouland AJ; DesGroseillers L
    J Virol; 2007 Jun; 81(12):6216-30. PubMed ID: 17428849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tsg101 control of human immunodeficiency virus type 1 Gag trafficking and release.
    Goff A; Ehrlich LS; Cohen SN; Carter CA
    J Virol; 2003 Sep; 77(17):9173-82. PubMed ID: 12915533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human immunodeficiency virus type 1 Vpu protein tethered to the CD4 extracellular domain is localized to the plasma membrane and is biologically active in the secretory pathway of mammalian cells: implications for the mechanisms of Vpu function.
    Raja NU; Jabbar MA
    Virology; 1996 Jun; 220(1):141-51. PubMed ID: 8659106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane.
    Finzi A; Orthwein A; Mercier J; Cohen EA
    J Virol; 2007 Jul; 81(14):7476-90. PubMed ID: 17507489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
    Wu X; Liu H; Xiao H; Kappes JC
    Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.